News & Blog

Tag Archives: GBM

So You Heard About Rintega? Here’s What’s Next for Brain Tumor Drug Development

Last week, news broke that a promising clinical trial of a new type of treatment for a subset of glioblastoma (GBM) patients – an immunotherapeutic vaccine made by Celldex Therapeutics called RINTEGA (rindopepimut) – was discontinued because patients receiving the investigational therapy were not doing better than patients in the control arm. As we said in our statement regarding […]

A Roadmap for a Successful 2016: Focus. Community. Leadership.

Just like the President of the United States, governors and mayors across country who take every January to deliver State of the Union/State/City addresses, I didn’t want to let this month slip by without letting all of you – our valued community – know how NBTS plans to make the most of the trust, time, […]

The Neuro-Oncology Field Weighs-in: Predictions & Hopes for Brain Tumor Research Advances in 2016

In 2015 we saw a major swing toward positive momentum in the fight against brain tumors, and we’re carrying it into 2016. Last year we experienced the first new treatment for newly diagnosed glioblastoma patients approved to enter the market in nearly a decade, as well as the biggest single-year increase in funding for the […]

Share